Literature DB >> 13485179

Mortality and survival in surgically treated cancer of the breast: a statistical summary of some experience of the Mayo Clinic.

J BERKSON, S W HARRINGTON, O T CLAGETT, J W KIRKLIN, M B DOCKERTY, J R McDONALD.   

Abstract

Entities:  

Keywords:  BREAST NEOPLASMS/statistics

Mesh:

Year:  1957        PMID: 13485179

Source DB:  PubMed          Journal:  Proc Staff Meet Mayo Clin        ISSN: 0092-699X


× No keyword cloud information.
  9 in total

1.  Fallibility in carcinoma of the breast.

Authors:  H ATKINS
Journal:  Proc R Soc Med       Date:  1960-11

Review 2.  CANCER STUDIES. CANCER OF THE BREAST.

Authors:  J W CLINE
Journal:  Calif Med       Date:  1963-12

3.  Treatment of 126 cases of malignant melanoma: long term results.

Authors:  S L GUMPORT; H W MEYER
Journal:  Ann Surg       Date:  1959-12       Impact factor: 12.969

4.  [Is there a warning sign for breast carcinoma carriers in the individual and family history?].

Authors:  K SOLTH; H LOEHR; M SCHMIDT; I SAURBIER
Journal:  Z Krebsforsch       Date:  1959

5.  Some factors in the choice of treatment of carcinoma of the breast.

Authors:  E B MILLER; C S KENNEDY
Journal:  Ann Surg       Date:  1959-12       Impact factor: 12.969

6.  Long-term survival experience of female patients with genital cancer.

Authors:  J L Haybittle; E M Kingsley-Pillers
Journal:  Br J Cancer       Date:  1988-03       Impact factor: 7.640

7.  CARCINOMA OF THE BREAST IN NIGERIA. A REVIEW OF 100 PATIENTS.

Authors:  J B PEARSON
Journal:  Br J Cancer       Date:  1963-12       Impact factor: 7.640

8.  THE INFLUENCE OF DELAY ON THE NATURAL HISTORY AND PROGNOSIS OF BREAST CANCER: A STUDY OF CASES FOLLOWED FOR FIVE TO TWENTY YEARS.

Authors:  H J BLOOM
Journal:  Br J Cancer       Date:  1965-06       Impact factor: 7.640

9.  An analysis of clinical and histopathological features in 101 cases of carcinoma of breast in women under 35 years of age.

Authors:  T G Brightmore; W P Greening; I Hamlin
Journal:  Br J Cancer       Date:  1970-12       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.